Searched for
LOPINAVIR
Cipla, DNDi launch 4-in-1 antiretroviral treatment for children with HIVSouth African Health Products Regulatory Authority (SAHPRA) has approved the sweet-tasting, heat-stable and '4-in-1' fixed-dose combination...- India to review use of remdesivir, hydroxychloroquine for Covid therapyIndian Council of Medical Research (ICMR) director general Balram Bhargava told ET that clinical protocols will be updated after discussion...
- WHO study says remdesivir did not cut hospital stay or mortality in COVID-19 patientsThe study found the regimens appeared to have little or no effect on 28-day mortality or the length of the in-hospital course among patient...
- WHO ending hydroxycholorquine trial for COVIDWHO says a review of the interim results showed hydroxychloroquine and lopinavir/ritonavir "produce little or no reduction in the mortality...
- Antiviral hyped as potential Covid treatment "ineffective", finds major studyLopinavir-ritonavir showed “no beneficial effect” in hospitalised patients not on ventilators, as per University of Oxford’s Recovery trial...
- Recruitment for HCQ solidarity trial stopped in IndiaThe decision to scrap HCQ testing was based on evidence from the Solidarity Trial, the UK’s Recovery Trial and a Cochrane review of other e...
- India to test four drugs for Covid-19 as part of the WHO solidarity trialOn Wednesday the Indian Council of Medical Research (ICMR) announced that potential anti-viral agents, Remdesivir, Chloroquine/Hydroxychlor...
- India to test four drugs as part of WHO trialPotential anti-viral agents remdesivir, chloroquine/hydroxychloroquine, lopinavir-ritonavir and lopinavir-ritonavir with interferon will be...
- 'Govt using telemedicine to reduce doctors’ exposure'Details of patients, who are otherwise healthy, are sent to doctors who then advise workers on how to manage the patients
- COVID-19: Orders for over 10 crore anti-malarial hydroxychloroquine tablets placed by CentreThe Indian Council of Medical Research (ICMR) has recommended the anti-malarial drug for those involved in the care of suspected or confirm...
- Kerala: British national given HIV antiretroviral drugs to treat coronavirus now tests negativeA British national, who was administered HIV antiretroviral drugs for treating his coronavirus infection, has tested negative, doctors at t...
- Coronavirus: HIV drugs can be used in severe cases, says ICMRAccording to ICMR experts, the inclusion of the anti-HIV drugs for treating Covid-19 was based on earlier evidence about their effectivenes...
- Covid-19: China stalls supplies, India faces anti-retroviral shortageAntiretrovirals - used for treating coronavirus - are manufactured by around five major pharma companies in India. The demand for such drug...
- Pharma department tells companies to step up manufacture of anti-HIV drugsExperts meets pharma execs seeking enough stock of Lopinavir and Ritonavir to be kept ready for India.
- National Pharmaceutical Pricing Authority seeks drug stock, pricing dataThe regulator had earlier asked the drug makers and groups to share details regarding the price movement, production details and inventory ...
- DGCI approves 'restricted use' of anti-HIV drugs on nCoV patientsAccording to government sources, apex health research body Indian Council of Medical Research (ICMR) had sought an emergency approval from ...
- Battling the epidemic: India readies treatment protocol for CoronavirusThe Indian Council of Medical Research (ICMR) has approval from the Drug Controller General of India (DCGI) to allow a combination of lopin...
- DCGI eases norms for HIV paediatric drugs productionThe decision comes two months after ET reported how payment delays and regulatory hurdles had forced companies such as Cipla to stop produc...
- Cipla gets USFDA nod for Lopinavir, Ritonavir oral pelletsCipla has received approval from US health regulator USFDA for Lopinavir and Ritonavir oral pellets used for treating AIDS in infants and y...
- Abbott patent application for HIV drug spurnedBesides I-MAK, a few local HIV drug makers such as Cipla and US-based Mylan-owned Matrix Laboratories had also opposed Abbott's attempt to ...
Load More
